Global Liver Cancer Diagnostics Market by Test Type (Biopsy, Endoscopy, Imaging), End User (Academic & Research Institutes, Hospitals & Diagnostic Laboratories, Pharmaceutical & CRO Laboratories) - Forecast 2024-2030- Product Image

Sale

Global Liver Cancer Diagnostics Market by Test Type (Biopsy, Endoscopy, Imaging), End User (Academic & Research Institutes, Hospitals & Diagnostic Laboratories, Pharmaceutical & CRO Laboratories) - Forecast 2024-2030

Report
186 Pages
March 2024
Region: Global
360iResearch™
ID: 5716289

UP TO €845EUR$875USD£723GBP OFF until Dec 31^st 2024

The Liver Cancer Diagnostics Market size was estimated at USD 9.41 billion in 2023, USD 10.05 billion in 2024, and is expected to grow at a CAGR of 6.62% to reach USD 14.74 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Liver Cancer Diagnostics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Liver Cancer Diagnostics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Liver Cancer Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Accuray Incorporated, Biocartis NV, C.R. Bard Inc., Elekta AB, Epigenomics AG, F. Hoffmann-La Roche Ltd., Fujifilm Medical Systems U.S.A., Inc., Illumina, Inc., Koninklijke Philips N.V., Myriad Genetics, Inc., Qiagen N.V., Siemens AG, Sysmex Corporation, and Thermo Fisher Scientific, Inc.

Market Segmentation & Coverage

This research report categorizes the Liver Cancer Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

Test Type
- Biopsy
- Endoscopy
- Imaging
- Laboratory tests
  - Biomarkers
    - Enzymes & Isoenzymes
    - Growth Factors & Receptors
    - Molecular Markers
    - Oncofetal & Glycoprotein Antigens
    - Pathological Biomarkers
  - Blood Tests
End User
- Academic & Research Institutes
- Hospitals & Diagnostic Laboratories
- Pharmaceutical & CRO Laboratories

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Liver Cancer Diagnostics Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Liver Cancer Diagnostics Market?
What are the technology trends and regulatory frameworks in the Liver Cancer Diagnostics Market?
What is the market share of the leading vendors in the Liver Cancer Diagnostics Market?
Which modes and strategic moves are suitable for entering the Liver Cancer Diagnostics Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Liver Cancer Diagnostics Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing Incidence of liver cancer globally
5.1.1.2. Favorable reimbursement framework for liver cancer diagnosis
5.1.1.3. Growing number of liver cancer screening programs
5.1.2. Restraints
5.1.2.1. Limited skilled and trained professionals
5.1.3. Opportunities
5.1.3.1. Technological advancements in cancer diagnosis equipment
5.1.3.2. Focus on development of effective diagnostics
5.1.4. Challenges
5.1.4.1. Limitations of liver cancer diagnostics
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization

6. Liver Cancer Diagnostics Market, by Test Type

6.1. Introduction
6.2. Biopsy
6.3. Endoscopy
6.4. Imaging
6.5. Laboratory tests
6.6.1. Biomarkers
6.6.2.1. Enzymes & Isoenzymes
6.6.2.2. Growth Factors & Receptors
6.6.2.3. Molecular Markers
6.6.2.4. Oncofetal & Glycoprotein Antigens
6.6.2.5. Pathological Biomarkers
6.6.2. Blood Tests

7. Liver Cancer Diagnostics Market, by End User

7.1. Introduction
7.2. Academic & Research Institutes
7.3. Hospitals & Diagnostic Laboratories
7.4. Pharmaceutical & CRO Laboratories

8. Americas Liver Cancer Diagnostics Market

8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Liver Cancer Diagnostics Market

9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Liver Cancer Diagnostics Market

10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape

11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

12.1. Key Company Profiles
12.1.1. Abbott Laboratories
12.1.2. Accuray Incorporated
12.1.3. Biocartis NV
12.1.4. C.R. Bard Inc.
12.1.5. Elekta AB
12.1.6. Epigenomics AG
12.1.7. F. Hoffmann-La Roche Ltd.
12.1.8. Fujifilm Medical Systems U.S.A., Inc.
12.1.9. Illumina, Inc.
12.1.10. Koninklijke Philips N.V.
12.1.11. Myriad Genetics, Inc.
12.1.12. Qiagen N.V.
12.1.13. Siemens AG
12.1.14. Sysmex Corporation
12.1.15. Thermo Fisher Scientific, Inc.
12.2. Key Product Portfolio

13. Appendix

13.1. Discussion Guide
13.2. License & Pricing

List of Figures

FIGURE 1. LIVER CANCER DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. LIVER CANCER DIAGNOSTICS MARKET SIZE, 2022 VS 2030
FIGURE 3. LIVER CANCER DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. LIVER CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. LIVER CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. LIVER CANCER DIAGNOSTICS MARKET DYNAMICS
FIGURE 7. LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2022 VS 2030 (%)
FIGURE 8. LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2022 VS 2030 (%)
FIGURE 10. LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS LIVER CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 12. AMERICAS LIVER CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES LIVER CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 14. UNITED STATES LIVER CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC LIVER CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC LIVER CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. LIVER CANCER DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 20. LIVER CANCER DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2022

List of Tables

TABLE 1. LIVER CANCER DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. LIVER CANCER DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 6. LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. LIVER CANCER DIAGNOSTICS MARKET SIZE, BY ENDOSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. LIVER CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. LIVER CANCER DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. LIVER CANCER DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2030 (USD MILLION)
TABLE 11. LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 13. LIVER CANCER DIAGNOSTICS MARKET SIZE, BY ENZYMES & ISOENZYMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. LIVER CANCER DIAGNOSTICS MARKET SIZE, BY GROWTH FACTORS & RECEPTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. LIVER CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR MARKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. LIVER CANCER DIAGNOSTICS MARKET SIZE, BY ONCOFETAL & GLYCOPROTEIN ANTIGENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. LIVER CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGICAL BIOMARKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 20. LIVER CANCER DIAGNOSTICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. LIVER CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. LIVER CANCER DIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL & CRO LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS LIVER CANCER DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS LIVER CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 33. BRAZIL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2030 (USD MILLION)
TABLE 34. BRAZIL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 36. CANADA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 37. CANADA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2030 (USD MILLION)
TABLE 38. CANADA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 39. CANADA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 40. MEXICO LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 41. MEXICO LIVER CANCER DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2030 (USD MILLION)
TABLE 42. MEXICO LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 43. MEXICO LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES LIVER CANCER DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES LIVER CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC LIVER CANCER DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2030 (USD MILLION)
TABLE 51. ASIA-PACIFIC LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 52. ASIA-PACIFIC LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 53. ASIA-PACIFIC LIVER CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 54. AUSTRALIA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 55. AUSTRALIA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2030 (USD MILLION)
TABLE 56. AUSTRALIA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 57. AUSTRALIA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. CHINA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 59. CHINA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2030 (USD MILLION)
TABLE 60. CHINA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 61. CHINA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 62. INDIA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 63. INDIA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2030 (USD MILLION)
TABLE 64. INDIA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 65. INDIA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. INDONESIA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 67. INDONESIA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2030 (USD MILLION)
TABLE 68. INDONESIA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 69. INDONESIA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 70. JAPAN LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 71. JAPAN LIVER CANCER DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2030 (USD MILLION)
TABLE 72. JAPAN LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 73. JAPAN LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. MALAYSIA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 75. MALAYSIA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2030 (USD MILLION)
TABLE 76. MALAYSIA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 77. MALAYSIA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. PHILIPPINES LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 79. PHILIPPINES LIVER CANCER DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2030 (USD MILLION)
TABLE 80. PHILIPPINES LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 81. PHILIPPINES LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 82. SINGAPORE LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 83. SINGAPORE LIVER CANCER DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2030 (USD MILLION)
TABLE 84. SINGAPORE LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 85. SINGAPORE LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 86. SOUTH KOREA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 87. SOUTH KOREA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2030 (USD MILLION)
TABLE 88. SOUTH KOREA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 89. SOUTH KOREA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. TAIWAN LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 91. TAIWAN LIVER CANCER DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2030 (USD MILLION)
TABLE 92. TAIWAN LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 93. TAIWAN LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. THAILAND LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 95. THAILAND LIVER CANCER DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2030 (USD MILLION)
TABLE 96. THAILAND LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 97. THAILAND LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 98. VIETNAM LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 99. VIETNAM LIVER CANCER DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2030 (USD MILLION)
TABLE 100. VIETNAM LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 101. VIETNAM LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 107. DENMARK LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 108. DENMARK LIVER CANCER DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2030 (USD MILLION)
TABLE 109. DENMARK LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 110. DENMARK LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. EGYPT LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 112. EGYPT LIVER CANCER DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2030 (USD MILLION)
TABLE 113. EGYPT LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 114. EGYPT LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 115. FINLAND LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 116. FINLAND LIVER CANCER DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2030 (USD MILLION)
TABLE 117. FINLAND LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 118. FINLAND LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. FRANCE LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 120. FRANCE LIVER CANCER DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2030 (USD MILLION)
TABLE 121. FRANCE LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 122. FRANCE LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. GERMANY LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 124. GERMANY LIVER CANCER DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2030 (USD MILLION)
TABLE 125. GERMANY LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 126. GERMANY LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 127. ISRAEL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 128. ISRAEL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2030 (USD MILLION)
TABLE 129. ISRAEL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 130. ISRAEL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. ITALY LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 132. ITALY LIVER CANCER DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2030 (USD MILLION)
TABLE 133. ITALY LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 134. ITALY LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 136. NETHERLANDS LIVER CANCER DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 138. NETHERLANDS LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. NIGERIA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 140. NIGERIA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2030 (USD MILLION)
TABLE 141. NIGERIA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 142. NIGERIA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 143. NORWAY LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 144. NORWAY LIVER CANCER DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2030 (USD MILLION)
TABLE 145. NORWAY LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 146. NORWAY LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. POLAND LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 148. POLAND LIVER CANCER DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2030 (USD MILLION)
TABLE 149. POLAND LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 150. POLAND LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 151. QATAR LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 152. QATAR LIVER CANCER DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2030 (USD MILLION)
TABLE 153. QATAR LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 154. QATAR LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2030 (USD MILLION)
TABLE 157. RUSSIA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. SPAIN LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 168. SPAIN LIVER CANCER DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2030 (USD MILLION)
TABLE 169. SPAIN LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 170. SPAIN LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 171. SWEDEN LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 172. SWEDEN LIVER CANCER DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2030 (USD MILLION)
TABLE 173. SWEDEN LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 174. SWEDEN LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 175. SWITZERLAND LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 176. SWITZERLAND LIVER CANCER DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2030 (USD MILLION)
TABLE 177. SWITZERLAND LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 178. SWITZERLAND LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 179. TURKEY LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 180. TURKEY LIVER CANCER DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2030 (USD MILLION)
TABLE 181. TURKEY LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 182. TURKEY LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES LIVER CANCER DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM LIVER CANCER DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 191. LIVER CANCER DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 192. LIVER CANCER DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2022
TABLE 193. LIVER CANCER DIAGNOSTICS MARKET LICENSE & PRICING

Companies Mentioned

Abbott Laboratories
Accuray Incorporated
Biocartis NV
C.R. Bard Inc.
Elekta AB
Epigenomics AG
F. Hoffmann-La Roche Ltd.
Fujifilm Medical Systems U.S.A., Inc.
Illumina, Inc.
Koninklijke Philips N.V.
Myriad Genetics, Inc.
Qiagen N.V.
Siemens AG
Sysmex Corporation
Thermo Fisher Scientific, Inc.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	186
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 10.05 Billion
Forecasted Market Value ( USD ) by 2030	$ 14.74 Billion
Compound Annual Growth Rate	6.6%
Regions Covered	Global
No. of Companies Mentioned	15

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3259EUR$3,374USD£2,789GBP €3621EUR$3,749USD£3,099GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4128EUR$4,274USD£3,533GBP €4587EUR$4,749USD£3,925GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€4997EUR$5,174USD£4,276GBP €5552EUR$5,749USD£4,752GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5866EUR$6,074USD£5,020GBP €6518EUR$6,749USD£5,578GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7605EUR$7,874USD£6,508GBP €8450EUR$8,749USD£7,231GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Liver Cancer Diagnostics Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030

Liver Cancer Diagnostics Global Market Report 2024

Liver Cancer Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2030

Cancer Diagnostics Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Companies Analysis

Pancreatic Cancer Diagnostic Market Size, Share & Trends Analysis Report By Product, By Test Type (Imaging Test, Biopsy, Blood Test, Others), By Cancer Type (Exocrine, Endocrine), By End-use, By Region, And Segment Forecasts, 2023 - 2030

About the Liver Cancer Diagnostics Market